| SpectraBase Spectrum ID |
JFgfTXqSShc |
| Name |
Butonitazene |
| Classification |
Nitazene opioid designer drug |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
424.247440903 u |
| Formula |
C24H32N4O3 |
| InChI |
InChI=1S/C24H32N4O3/c1-4-7-16-31-21-11-8-19(9-12-21)17-24-25-22-18-20(28(29)30)10-13-23(22)27(24)15-14-26(5-2)6-3/h8-13,18H,4-7,14-17H2,1-3H3 |
| InChIKey |
UZZPOLCDCVWLAZ-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
424.545 g/mol |
| Nominal Mass |
424 u |
| Quality |
1000 |
| Retention Index |
3614 |
| SMILES |
C=12N(C(=NC2=CC(=CC1)[N+](=O)[O-])CC1=CC=C(C=C1)OCCCC)CCN(CC)CC |
| SPLASH |
splash10-000i-9100000000-1f20883ca87faf64d21c |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
2-(2-(4-Butoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)-N,N-diethylethan-1-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_030948 |
